4

OWNERSHIP DOCUMENT

Company: Phathom Pharmaceuticals, Inc.
Filed: March 31, 2020
Period of Report: March 27, 2020
Accession Number: 0001104659-20-041240

View Document ↗ View on SEC.gov ↗